Arkolith/Insider Trading/DALS/Form 4

Section 32 Fund 3, LP

Director, 10% OwnerDA32 Life Science Tech Acquisition Corp. (DALS) · full profile →Form 4 · filed Aug 3, 2021
Net Buying
Open-Market Buys
$8.0M
Open-Market Sells
$0
Net Open-Market Flow
$8.0M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 30, 2021Buy(P)800K$10.00$8.0M800K
Jul 30, 2021Grant(A)650K$10.00$6.5M1.4M

Transaction Codes

P
Open-market purchase
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-21-031450) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML